Singapore markets close in 7 hours 39 minutes
Straits Times Index
3,251.00 -42.13 (-1.28%) Nikkei
37,979.84 -480.24 (-1.25%) Hang Seng
17,201.27 +372.34 (+2.21%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,456.30 -2,250.84 (-3.37%) CMC Crypto 200
1,394.81 -29.29 (-2.06%)
GILD Jan 2025 60.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:15PM EDT. Market open.
| Previous close | 2.7100 |
| Open | 2.8000 |
| Bid | 2.6700 |
| Ask | 2.7500 |
| Strike | 60.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.7500 - 2.8200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.57k |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.